Hematologist Arthur Nienhuis Named 2009 ASH Mentor Award Recipient

Wednesday, November 4, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

St. Jude Children's Research Hospital doctor to receive the American Society of Hematology award at the organization's annual meeting

MEMPHIS, Tenn., Nov. 2 /PRNewswire-USNewswire/ -- Arthur Nienhuis, M.D., of St. Jude Children's Research Hospital, is the recipient of the 2009 Mentor Award from the American Society of Hematology (ASH). Nienhuis will receive the honor at the society's annual meeting this December in New Orleans.

ASH is the world's largest professional society concerned with the causes and treatments of blood disorders. The Mentor Award recognizes hematologists who have excelled at mentoring trainees and colleagues. Award recipients are chosen because they have shown a sustained commitment to mentoring; have made a significant, positive impact on their mentees' careers; and have advanced research and patient care in the field of hematology through those they train.

Two awards are given each year--one in the basic sciences and one to an outstanding clinical investigator mentor. Nienhuis will receive the award for clinical investigation.

"Dr. Nienhuis' dedication and attention to those he mentors has molded a new generation of researchers, and his passion for helping shape junior and senior faculty continues today," said Dr. William E. Evans, St. Jude director and CEO. "His long-standing commitment to trainees and colleagues has prepared many of today's leaders in hematology around the world."

Nienhuis' expertise in bone marrow transplantation, gene therapy and genetic testing paved the way for many advances at St. Jude, including breakthroughs in sickle cell disease and other hematological disorders. He also made significant achievements in the fields of cell therapy, HIV/AIDS research and inherited immunodeficiencies. Through his work, Nienhuis improved care for patients, while helping other researchers carry on the fight against catastrophic childhood disease.

Nienhuis has received numerous honors, including being named to the National Cancer Advisory Board by former President Bill Clinton in 1998. That same year, Nienhuis was awarded the Stratton Medal by ASH, one of the society's highest honors for an outstanding body of work in hematology. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences. Nienhuis served as fourth director and CEO of St. Jude from 1993 to 2004.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fundraising organization. For more information, please visit www.stjude.org.

SOURCE St. Jude Children's Research Hospital

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store